ARTICLE | Company News
Protalix board of directors update
July 28, 2014 7:00 AM UTC
Protalix BioTherapeutics Inc. (NYSE-M:PLX; Tel Aviv:PLX), Carmiel, Israel Business: Endocrine/Metabolic, Biosimilars, Biomanufacturing Appointed: Shlomo Yanai as chairman, formerly president and CEO o...